531726 Stock Overview
Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Panchsheel Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹215.10 |
| 52 Week High | ₹309.90 |
| 52 Week Low | ₹173.00 |
| Beta | 0.57 |
| 1 Month Change | -2.40% |
| 3 Month Change | -14.30% |
| 1 Year Change | 9.94% |
| 3 Year Change | 78.43% |
| 5 Year Change | 643.65% |
| Change since IPO | 10,655.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531726 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.0% | 0.8% | -4.2% |
| 1Y | 9.9% | 39.7% | 19.1% |
Return vs Industry: 531726 underperformed the Indian Pharmaceuticals industry which returned 39.7% over the past year.
Return vs Market: 531726 underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility
| 531726 volatility | |
|---|---|
| 531726 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 531726 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531726's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 178 | Mahendra Turakhia | www.panchsheelorganics.com |
Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. In addition, it provides over the counter products comprising healthcare and FMCG products, such as antibiotics, cough and cold remedies, pain relieve ranges, anti-inflammatory products, analgesics, protein health drinks, and contraceptives, as well as calcium, iron, and multivitamin supplements; veterinary medicines comprising APIs for animal health and feed supplements; pellets, direct compression granules, and taste masked granules; fitness and health care products; and nutraceuticals.
Panchsheel Organics Limited Fundamentals Summary
| 531726 fundamental statistics | |
|---|---|
| Market cap | ₹2.53b |
| Earnings (TTM) | ₹142.50m |
| Revenue (TTM) | ₹1.10b |
17.8x
P/E Ratio2.3x
P/S RatioIs 531726 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531726 income statement (TTM) | |
|---|---|
| Revenue | ₹1.10b |
| Cost of Revenue | ₹732.95m |
| Gross Profit | ₹368.24m |
| Other Expenses | ₹225.74m |
| Earnings | ₹142.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.09 |
| Gross Margin | 33.44% |
| Net Profit Margin | 12.94% |
| Debt/Equity Ratio | 4.1% |
How did 531726 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield28%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Panchsheel Organics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|